The State Street SPDR S&P Biotech ETF (XBI) experienced an outflow of approximately $221.5 million this past week, marking a 2.1% decrease in shares outstanding, from 67,375,000 to 65,975,000. This change occurred in the context of a broader interest in biotech stocks, with key holdings such as Twist Bioscience Corp (TWST) up 2.3%, Halozyme Therapeutics Inc (HALO) up 0.5%, and Natera Inc (NTRA) up 3.4%.
Over the past year, XBI has seen a price range from $95.74 to $169.89, with the most recent trade at $160.08. This is compared against its 200-day moving average, a technical analysis benchmark used by investors.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
